Position in IDYA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,381,946
-$99,799 QoQ
Shares Held
71,487
-0.4% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $156,743,120 across 93 Biotechnology names. IDYA ranks #20 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
496,682 | $23,825,835 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
66,457 | $5,535,203 | |
| 3 | CGON |
CG Oncology, Inc.
|
68,737 | $4,652,120 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
49,128 | $4,538,444 | |
| 5 | CELC |
Celcuity Inc.
|
37,663 | $4,298,854 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
104,058 | $4,186,253 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
67,723 | $3,938,092 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
45,586 | $3,836,973 |
All Filings in IDYA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,381,946 | 71,487 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,481,745 | 71,789 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,146,901 | 42,150 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $993,047 | 47,243 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,007,992 | 61,538 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,796,224 | 69,892 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,055,715 | 64,890 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,073,315 | 59,052 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,280,926 | 51,981 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,510,371 | 42,450 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,146,083 | 42,479 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $989,608 | 42,111 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $319,422 | 21,409 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $316,365 | 22,925 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||